Breaking News, Collaborations & Alliances

Promethera Biosciences and Shibuya Form Collaboration

Will establish breakthrough cell therapy manufacturing platform

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Promethera Biosciences SA and Shibuya Corporation have formed a collaboration to establish a high-throughput, commercial-scale and clinical-grade cell therapy and regenerative medicine manufacturing platform. For Promethera, the collaboration will act as a cornerstone to optimize and expand the manufacturing capabilities for its current and future portfolio of liver-derived cell therapies to treat Non-Alcoholic Steatohepatitis (NASH), acute-on-chronic liver-failure (ACLF) and other indications. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters